Latest Strategic Transformation News

Senetas Corporation has streamlined its operations following the sale of Votiro, reporting a strong financial position and unveiling plans for a significant capital return and share consolidation.

Invex Therapeutics has appointed two new non-executive directors and joint company secretaries, signaling a refreshed governance structure alongside a change of company address.

Nine Entertainment reported a resilient FY25 with strategic transformation gains, digital subscription growth, and a major capital return following the sale of its Domain stake. Leadership changes and regulatory challenges frame its path forward.

Altech Batteries confirms the strategic importance of its AMPower Agreement, enabling immediate sales and cash flow, while detailing a recent $6 million capital raising and addressing trading compliance issues.

Jayride Group Limited reported a $322K net cash outflow for the September quarter as it shifts from airport transfers to a SaaS mobility platform, raising $200K through convertible notes to support its transformation.

Westpac reported a resilient full-year 2025 performance with modest profit decline, robust loan and deposit growth, and ongoing strategic initiatives aimed at simplifying operations and enhancing customer experience.

Westpac Banking Corporation reported a solid $6.9 billion statutory net profit for 2025, maintaining strong capital and credit quality while increasing dividends. The bank’s ongoing transformation and disciplined growth underpin its outlook amid evolving economic conditions.

Mach7 Technologies reports a pivotal first quarter for FY26, marked by the initial go-live of a major U.S. Veterans Health Administration contract, leadership changes, and a strategic business reset.

Warriedar Resources reports robust drilling results confirming extensions of high-grade gold and antimony mineralisation at key Western Australian projects, alongside an increased acquisition offer from Capricorn Metals.

EQT Holdings Limited reported a robust 60% increase in net profit after tax for FY25, completing a strategic transformation while navigating significant regulatory challenges. The company outlined a growth-focused strategy for FY26, emphasizing digital innovation and margin improvement.

CSL Limited has revised its financial outlook for FY26, citing lower US influenza vaccination rates and government cost controls in China, while postponing the planned demerger of its Seqirus vaccine business and announcing a major cost-saving program.

Nuix announces the departure of CEO Jonathan Rubinsztein after four years of transformative leadership, with an interim CEO to be appointed amid a global search for his successor.